华东医药财务报表 |
评论“华东医药” |
|
|
项目 |
2001年 |
2000年 |
1999年 |
一、主营业务收入 |
1,886,418,432.00 |
1,617,730,944.00 |
1,245,869,312.00 |
减:折扣与折让 |
0.00 |
|
|
主营业务收入净额 |
1,886,418,432.00 |
1,617,730,944.00 |
1,245,869,312.00 |
减:主营业务成本 |
1,580,170,880.00 |
1,343,791,616.00 |
1,032,413,696.00 |
主营业务税金及附加 |
3,758,984.00 |
3,767,930.00 |
1,726,225.12 |
二、主营业务利润 |
302,488,512.00 |
270,171,360.00 |
211,729,424.00 |
加:其它业务利润 |
802,121.56 |
2,699,859.50 |
2,527,569.25 |
减:存货跌价损失 |
0.00 |
-292,295.22 |
401,756.16 |
营业费用 |
115,314,160.00 |
101,900,792.00 |
76,225,080.00 |
管理费用 |
88,601,672.00 |
91,587,296.00 |
63,801,448.00 |
财务费用 |
8,496,237.00 |
10,102,625.00 |
15,134,372.00 |
销售费用 |
|
|
|
三、营业利润 |
90,878,560.00 |
69,572,784.00 |
58,694,336.00 |
加:投资收益 |
6,168,547.00 |
397,967.06 |
-3,112,737.50 |
补贴收入 |
0.00 |
|
|
营业外收入 |
121,360.55 |
3,395,311.25 |
8,399,238.00 |
减:营业外支出 |
2,601,155.50 |
4,907,519.00 |
1,289,875.25 |
四、利润总额 |
94,567,312.00 |
68,458,544.00 |
62,690,964.00 |
减:所得税 |
27,767,708.00 |
12,883,717.00 |
13,025,551.00 |
减:少数股东损益 |
9,323,354.00 |
9,664,477.00 |
|
加:财政返还(含所得税返还) |
|
|
|
五、净利润 |
57,476,252.00 |
45,910,356.00 |
40,352,168.00 |
加:年初未分配利润 |
1,381,898.50 |
-7,294,112.50 |
-15,889,991.00 |
盈余公积金转入 |
0.00 |
|
|
六、可供分配的利润 |
58,858,148.00 |
38,616,240.00 |
24,462,176.00 |
减:提取法定公积金 |
5,710,624.00 |
4,598,955.50 |
4,026,724.00 |
提取法定公益金 |
2,855,312.00 |
2,299,477.75 |
2,013,362.00 |
七、可供股东分配的利润 |
50,292,212.00 |
31,717,808.00 |
18,422,090.00 |
减:应付优先股股利 |
0.00 |
|
|
提取任意盈余公积 |
|
|
|
提取任意公积 |
0.00 |
|
|
应付普通股股利 |
9,500,000.00 |
28,500,000.00 |
17,100,000.00 |
转做股本的普通股股利 |
0.00 |
|
|
|